Abstract
Introduction
Stroke is a leading cause of death and disability worldwide, with ischaemic stroke contributing towards 80% of all diagnosed strokes (1) . Monitoring brain recovery post-stroke allows more effective and realistic rehabilitation of patients, and is also important for researching new treatments. However, there are few studies regarding the longer-term recovery after a stroke. The majority of brain recovery occurs within the first 30 days after a stroke, and many studies have focussed on this more immediate recovery of the brain (2, 3).
However, recovery processes can continue for at least 6 months (3). Here, a multi-modal imaging approach is used to study recovery of an ischaemic stroke in a pre-clinical model, three months post-stroke.
During ischaemic stroke, there is a lack of oxygen and nutrients delivered to an area of the brain, and an infarct (an area of dead tissue) is formed. The tissue surrounding the infarct is moderately ischaemic but can survive for a short period of time, and is known as the penumbra. However, within days cells in the penumbra will also die, and the penumbra will become part of the infarct. This loss of tissue and neurons in the infarct will then be responsible for the final loss of functionality. Furthermore, remote areas which are connected to the infarct can also be affected.
Imaging techniques are ideal for studying the brain post-stroke, with conventional methods of diagnosing a stroke including computed tomography (CT) and magnetic resonance imaging (MRI). CT is preferred as it is cheaper and quicker, although MRI is much more sensitive in detecting acute ischaemic stroke (4) . Both CT and MRI are well-established clinical imaging tools and they can show where the infarct has occurred, and if thrombolysis is necessary and feasible (4) (5) (6) . MRI is an important imaging modality used to monitor the brain acutely after a stroke; however other imaging modalities such as functional MRI (fMRI) or PET are preferential for imaging long-term recovery, as they are able to image functionality in the brain.
fMRI measures blood flow which is coupled to brain activity, and so can detect functional activity in the brain as oxygen is delivered from the blood to activated brain regions. Studies have shown that fMRI is a useful imaging tool for monitoring recovery post-stroke (7, 8) with
Loubinoux et al showing that fMRI maps give a better indication of behavioural outcome
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than total infarct volume as determined by MRI (9) . PET is a highly sensitive technique where a radiolabelled molecule (tracer) is imaged in-vivo. As well as measuring blood flow, it can give information on other important aspects of stroke pathology, including inflammation (10) . Neuroinflammation and neurodegeneration are key markers of pathology post-stroke, with neurodegeneration being the loss of neuronal integrity, which can include loss of function and structure. Numerous PET tracers have been developed to image neuroinflammation through expression of the translocator protein 18kDa (TSPO) by glial cells and infiltrating macrophages (11) (12) (13) . There is, however, a lack of reliable and broadly accepted biomarkers to image neurodegeneration with PET. The sigma-1 receptor (S1R) has been suggested as a potential pan-neuronal biomarker suitable for PET imaging, and several tracers have been developed for this purpose (14, 15) .
The S1R is a neuronal biomarker, which is involved in the regulation of intracellular Ca 2+ signalling (16) . A stroke can cause a disruption of calcium signalling, resulting in neuronal cell death (17) . Here, TSPO and S1R tracers are used at three months post-stroke to monitor neuroinflammation and neurodegeneration in long-term recovery.
One drawback of PET is that it can only image one tracer at a time, and is therefore very much a targeted technique. Moreover, by using pre-determined tracers, PET is very much a hypothesis driven imaging technique. Conversely, mass-spectrometry imaging can investigate a large number of molecules at once without a priori knowledge. Matrix-assisted laser desorption ionisation mass spectrometry (MALDI-MS) imaging can image a large number of both exogenous and endogenous species in one experiment, and at very high spatial resolutions (10-100 μm). MALDI-MS has been used in previous studies to image the acute effects of lipid distributions post-stroke (18) , showing that lipid alterations are prominent shortly after stroke. Phospholipids play both a structural and a signalling role in the body, and are of particular abundance in the brain. These phospholipids undergo changes after a traumatic brain injury such as stroke, with phospholipid degradation being recognised as a promoter of neuronal death (19) . Furthermore, lipids are involved in inflammation and cell death (20) (21) (22) . Thus, MALDI-MS lipid imaging data can enrich the in-vivo PET data regarding neuroinflammation and neurodegeneration, and they have been used so to study brain recovery three months post-stroke.
Methods

Materials
All solvents were purchased from Sigma-Aldrich, Gillingham, UK Phosphate buffered saline (PBS) was made using tablets purchased from Oxoid, Basingstoke, UK that were dissolved in distilled H2O.
1 mL Tween (T) (Fisher Scientific, Loughborough, UK) was added to PBS to make PBS-T.
Bovine serum albumin (BSA) (Sigma-Aldrich) was dissolved at 1 mg/mL PBST to make PBST-BSA solution.
Induction of focal cerebral ischaemia in rats
Wistar rats (350g, Charles River, Margate, UK) were allowed free access to food and water and were maintained under temperature, humidity, and light-controlled conditions. All procedures were performed under appropriate UK Home Office licences and adhered to the UK Animals (Scientific Procedures) Act (1986).
Middle cerebral artery occlusion (MCAO) was induced by 70 min transient ligature of the left middle cerebral artery trunk and common carotid artery with a 10-0 suture (Prolene, Ethicon, Somerville, NJ, USA) as described previously (23) under anaesthesia using isoflurane (2-3% for induction and 1.5-2% during surgery) in a mixture of 70% N2O and 30% O2. Core body temperature was maintained at 37.0±0.5°C throughout the surgery by a heating blanket (Homeothermic Blanket Control Unit; Harvard Apparatus, Edenbridge, UK). Occlusion and reperfusion were confirmed visually under the surgical microscope. After surgery, animals were returned to their home cages and allowed free access to water and food.
MRI
MCAO lesions were assessed by T2 weighted (T2W) MRI at 48h after stroke, using a 7-T, horizontal-bore magnet (Agilent Technologies, Cheadle, UK) interfaced to a Bruker Avance III console (Bruker Biospin, Coventry, UK) using a surface transmit-receive coil, as described previously (24) . Images were visualised using Anatomist software (http://brainvisa. This article is protected by copyright. All rights reserved. info), and an anatomical atlas as described in (25) was used to identify different brain regions.
PET
The two PET scans were acquired 5 days apart three months post-stroke. PET scans were performed on a Siemens Inveon® PET/CT scanner (Siemens Healthcare Ltd, Camberley, UK) for 60 minutes. The rat was anesthetized using isoflurane (induction 5%, 2-2.5%) and catheterized in the tail vein for tracer injection. Animal respiration and temperature were controlled using a pressure-sensitive pad and rectal probe (BioVet, m2m
Imaging Corp., Cleveland, OH, USA) and the body temperature was maintained at 37±0.7°C via the interface managed by the BioVet system. PET-CT was performed as previously described (24) . Briefly, a CT scan was performed prior to the PET acquisition for attenuation correction. The list mode emission data were histogrammed into 3D sinograms of 35 dynamic frames, normalized, corrected for dead-time, attenuation, scatter and radioactive decay, and reconstructed using OSEM3D (16 subsets and 4 iterations) into images of dimensions 128×128×159 voxels of volume 0.776×0.776×0.796mm³.
Sample preparation
After PET scanning, rats were promptly decapitated, and their brains removed and frozen in isopentane. Brains were stored at −80 °C. Brains were sectioned to 12 µm and thaw-mounted
onto indium tin oxide (ITO) slides (Sigma-Aldrich). Sections were washed based on a protocol modified from Wang et al (27) where 100 μL of 150 mM ammonium acetate (Sigma-Aldrich) was pipetted over the sections, and allowed to dry between washes. Sections were washed 10 times. Slides were sprayed with 10mg/ml 2,5-dihydroxybenzoic acid (DHB) (LaserBio Labs, Sophia-Antipolis, France) made up in 70:30 methanol:water and 0.1% trifluoroacetic acid (TFA), (Sigma-Aldrich) using the SunCollect TM (Sunchrom, Friedrichsdorf, Germany). Flow rate of 10 μL/min, 15 μL/min and 20 μL weres used for the first, second and third layers, respectively, followed by 27 layers at 25 μL/min.
MALDI-MS imaging
Imaging was performed on a MALDI-7090 TOF-TOF mass spectrometer (Shimadzu, Manchester, UK), equipped with a solid-state UV laser. Experiments were performed in positive ion reflectron mode, using 100 laser shots per profile and a laser beam diameter of 50 µm at the sample. The laser repetition rate was 500 Hz, and the spatial resolution was set to 80 µm. The blanking mass was set to m/z 50 and pulsed extraction to m/z 700. Images were normalised to the total ion current (TIC) using a Shimdzu MALDI imaging processing toolbox beta version and processed in BioMap (Novartis, Basel, Switzerland). Slides were washed with 70 % ethanol post imaging and stained with haematoxylin and eosin (H&E).
The images were compared with those in an anatomical atlas as described elsewhere (25) .
MALDI MS/MS
MALDI MS/MS experiments were performed on the MALDI-7090 mass spectrometer using collision induced dissociation (CID) (helium was used as the CID gas) and axial spatial distribution focussing (ASDF) (28) . Interpretation of the spectra was facilitated by using the LIPID MAPS Lipidomics Gateway database (http://www.lipidmaps.org) (29) .
H&E
H&E staining was carried out on the same sections as the MALDI-MS imaging. Slides with mounted sections were immersed in xylene for two minutes, and then transferred to industrial
methylated spirit for 4 x 2 minutes. Sections were then immersed in tap water followed by 3 minutes in Harris haematoxylin (Sigma-Aldrich), a rinse in hot water, and a one second dip in eosin (Leica, Milton Keynes, UK). Slides were transferred to industrial methylated spirit for (4 x 2 minutes), then to xylene (4 x 2 minutes), and left to dry. Aqueous mounting media (Vector labs, Burlingame, CA, USA) were used to mount coverslips (VWR, Lutterworth, UK) onto slides, which were left overnight to dry. Images were acquired using a [20x/0.80
Plan Apo] objective using the 3D Histech Pannoramic 250 Flash II slide scanner, and processed using Pannoramic viewer (3D HISTECH, Budapest, Hungary).
Immunofluorescence
Tissue sections were fixed in ice-cold acetone (10 minutes). After drying, a DAKO pen 
Results and Discussion
MRI is an established technique for imaging the brain acutely after stroke. Here, MRI was carried out 48 hours post-ischaemic stroke, and shows a distinct infarct region in the right hemisphere (Figure 1) , revealing where the ischaemia has occurred.
Three months post-stroke, PET detects no substantial neuroinflammation in the peri-infarct area ( Figure 2 at day 42, microglial activation was still present, but it had moved away from the infarct region to the thalamus (36) . Here, PET scans showed that there was no defined TSPO overexpression relating to the brain anatomy or penumbra.
PET scans do not reveal any decrease in S1R in the infarct or the peri-infarct area compared with the rest of the brain (Figure 2) , suggesting remodelling or reorganisation of the brain structure around the initial infarct. The absence of a decrease in the S1R tracer Lipids play crucial roles in membrane formation, cell death, and cell signalling; and thus will be important in neurodegeneration and inflammation processes. Ex-vivo MALDI-MS imaging was carried out after PET scanning to investigate lipid changes in stroke recovery. Matrix effects in brain MALDI-MS images due to altered levels of sodium in the infarct post-stroke has been discussed by Lankeoff et al (37) , and therefore care should be taken when investigating sodiated lipid peaks in the infarct . Na + levels are expected to rise inside the cell acutely post-stroke due to the cessation of Na + /K + ATPase activity. However, because this study was carried out three months after ischaemia, the difference in sodium concentration across the brain is not expected to be a significant issue. Furthermore, Figure S3 (supporting information) shows an example of protonated and sodiated lipid species localising in the same area.
Unlike the PET data, MALDI-MS imaging showed clear molecular differences between the scar region, and the rest of the brain (Figure 3) . The different lipid profile of the scar from
that of normal brain tissue indicates that lipid metabolism is still altered in the brain three months after the ischaemic attack.
During an ischaemic attack there is an increase in the release of neurotransmitter glutamate, which causes intracellular Ca 2+ to rise, and phospholipases (A2, C, D) to be activated (38, 39) . The cytokines TNF-α and interleukin-1 upregulated during the pro-inflammatory response acutely after an ischaemic attack will also cause activation of phospholipases (40 
